Uncategorized Archives - Page 214 of 248

TuesdayJan 02, 2018 2:36 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Marks Milestone with Patent Approval

LXRP awarded broad-ranging U.S. patent for novel DehydraTECH™ drug delivery system Already scientifically proven to increase efficacy of cannabinoids IP protection opens myriad business opportunities Food bioscience company Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) just hit another major milestone in the disruption of drug delivery and administration. With 19 international patent applications filed encompassing 44 countries, Lexaria recently announced its reception of a broad-ranging U.S. patent award for its DehydraTECH™ as a delivery platform for a wide variety of active pharmaceutical ingredients (http://cnw.fm/2KT1d). The U.S. patent covers all cannabinoids including THC, fat soluble vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”) and…

TuesdayJan 02, 2018 1:15 pm

DOJA Cannabis Company Ltd. (CSE: DOJA) (OTC: DJACF) is “One to Watch”

Premium cannabis lifestyle brand founded by team that started SAXX Underwear® One of only 26 Health Canada licensed cannabis production facilities Canada’s recreational marijuana market estimated at up to $8.7 billion Initial cannabis harvests are complete; awaiting Health Canada pre-sales inspection DOJA Cannabis Company Ltd. (CSE: DOJA) (OTC: DJACF) is a premium cannabis lifestyle brand featuring the highest quality handcrafted strains in Canada. DOJA’s wholly owned subsidiary, Northern Lights Marijuana Company, is a Health Canada licensed cannabis producer located in Kelowna within the heart of British Columbia’s picturesque Okanagan Valley. Famous as the “Napa of the North,” Kelowna and its…

FridayDec 29, 2017 2:04 pm

Skinvisible, Inc. (SKVI) Partnership with Quoin Focuses on Population’s Pain Needs

Non-binding proposed merger announced on November 27, 2017 Quoin merger expected to deliver non-opioid relief to post-surgical patients Over-65 population with advanced pain needs expected to double within next 30 years Skinvisible and Quoin proposed merger expected to deliver better results to patients Health professionals are preparing for an expected doubling of the 65 years and older population within the next 30 years, creating medical need to address the pain that often becomes a prevalent companion to age. While modern pharmaceuticals have developed opioids and non-steroidal therapies for reducing chronic pain, the drugs are often accompanied by addiction and unwanted…

ThursdayDec 28, 2017 1:54 pm

ChineseInvestors.com, Inc. (CIIX) CEO Remains Bullish on Bitcoin and Other Cryptocurrencies

Warren Wang, CEO of CIIX, said in a podcast interview that investors in China and the Chinese-speaking community in the U.S. and Canada want to learn more about bitcoin, cryptocurrencies CIIX doubles down on commitment to its bitcoin division, adding a bitcoin ATM in its California headquarters and broadcasting a daily video from the NYSE called ‘Bitcoin Multimillionaire’ Company’s goal in FY2018 is profit, lower costs and a greater than 100 percent YOY sales increase ChineseInvestors.com, Inc. (OTCQB: CIIX) CEO Warren Wang remains bullish on the future of bitcoin and other cryptocurrencies, and he recently said in a podcast interview…

ThursdayDec 28, 2017 12:59 pm

Skinvisible, Inc. (SKVI) and Quoin Poised to Tackle Opioid Crisis with Alternative Pain Therapies

A possible larger role for leading drug manufacturers, and the resulting opioid epidemic, is met with increased public and government demands for alternative therapies The Skinvisible and Quoin merger, with expected completion in 2018, will create an enterprise positioned to disrupt the $6 billion U.S. opioid market by producing and delivering non-opioid alternatives for pain management Quoin’s QRX001 is slated to provide alternative and effective pain management in the post-surgical setting, where 50 percent of opioid addictions start A recent article by the Washington Post (http://cnw.fm/J40mp) addressed the opioid crisis, suggesting a larger role by leading pharmaceutical drug manufacturers than…

WednesdayDec 27, 2017 3:49 pm

World Health Organization Officially Rules CBD Should Not be a Scheduled Drug

The World Health Organization (WHO) announced that “the cannabis compound CBD (Cannabidiol) should not be internationally scheduled as a controlled substance” (www.WHO.int) WHO has issued preliminary findings indicating that cannabidiol (CBD) shows “no indications of abuse or dependence potential” and “a good safety profile” MCOA is committed to the development of high quality CBD-based products The World Health Organization (“WHO”) officially recommended on December 14, 2017, that the chemical compound cannabidiol (CBD) no longer be internationally scheduled as a controlled substance. WHO has issued a preliminary report that found CBD to be non-addictive and generally safe. The CBD pre-review report…

WednesdayDec 27, 2017 3:07 pm

AppSwarm, Inc. (SWRM) Looking for New Developers of Creative Mobile Apps

Global app revenue approaching $77 billion AppSwarm incubates and accelerates emerging talent in crowded market Company building on gaming bedrock, adding business resources and cannabis industry networks In a crowded mobile app market where large global companies dominate the landscape, AppSwarm, Inc. (OTC: SWRM) is working to befriend smaller developers and creative thinkers who hope to elbow their way in and find an audience. The entrepreneur-incubating company has the expertise to identify promising developers who may need some assistance in getting their products to a solid revenue-building stage, as well as the resources needed to help those developers analyze the…

WednesdayDec 27, 2017 1:05 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Says Best is yet to Come in 2018

DehydraTECH™ is the company’s newly U.S.-patented disruptive drug delivery platform; LXRP CEO Chris Bunka says company is working on more applications for its technology in the treatment of Alzheimer’s disease, Parkinson’s disease, opioid addiction and more LXRP has a portfolio of patents issued in both the U.S. and Australia, plus 19 patent applications filed in the U.S. (and internationally using the Patent Cooperation Treaty), as well as national filings in 44 countries Company has diverse revenue streams, including out-licensing its technology to third parties with fees ranging from five to 10 percent of gross sales, as well as sales of…

WednesdayDec 27, 2017 12:24 pm

Medical Cannabis Payment Solutions (REFG) Prepares Seamless Transition for Payment Processing to Support Card Participation in Marijuana Industry

If Visa and MasterCard (or others) choose to participate in the marijuana industry in the future, REFG plans to offer quick, full spectrum payment processing REFG’s StateSourced payment gateway is Financial Crimes Enforcement Network (FinCEN) compliant Medical marijuana sales will grow to $13.3 billion by 2020, and adult recreational marijuana sales are expected to reach $11.2 billion by 2020, according to Forbes Medical Cannabis Payment Solutions (OTC: REFG) is ready for the future with a seamless transition in the event that Visa or MasterCard (or others) choose to participate in the marijuana industry. In the event of a transition, full…

TuesdayDec 26, 2017 2:38 pm

NeutriSci International, Inc. (OTCQB: NRXCF) (TSX.V: NU) (FRA: IN9) Completes Private Placement, Will Use Proceeds for Neuenergy® Marketing

Neuenergy is a chewable and revolutionary energy tablet powered by blueberries and anti-oxidants with no sugar or calories NeutriSci International names Glen Rehman as new CEO Company sees new opportunities for its product in the cannabinoid field, as well as new strategic partnerships NeutriSci International, Inc. (OTCQB: NRXCF) (TSX.V: NU) (FRANKFURT: IN9) recently announced that it has raised $499,999.95 in a non-brokered private placement (http://cnw.fm/C4cA1), with the proceeds to be used for marketing and advertising of Neuenergy®, its branded blueberry-powered energy chewable tablet (http://cnw.fm/Ll6n9). Funds will also go to the company for general corporate purposes. In addition, the company announced…